# NeurAxis, Inc. (NRXS): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for NeurAxis, Inc. (NRXS) is 24/100, ranked against 24,000+ stocks in 35 markets (Quality 34, Value 21, Momentum 52, each scored against its sector).

- StockRank: 24/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 34, Value 21, Momentum 52: each a 0-100 percentile within Healthcare.
- Position: #20,143 overall, #1,789 in Healthcare.
- Listing: United States, ASE; Healthcare / Biotechnology.
- Last close: 7.25 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 12K.

Source: https://moatmap.ai/stock/NRXS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker